Penny Cornelius v. HHS - Tdap, Guillain-Barre syndrome, Miller Fisher variant (2019)

Filed 2019-02-22Decided 2019-03-19Vaccine Tdap
compensated$82,500

Case summary [AI summaries can sometimes make mistakes]

Penny Cornelius filed a petition for compensation under the National Vaccine Injury Compensation Program, alleging that she developed Guillain-Barre syndrome (GBS), specifically the Miller Fisher variant, after receiving a tetanus-diphtheria-acellular pertussis (Tdap) vaccine on August 12, 2015. The Tdap vaccine is listed on the Vaccine Injury Table.

Respondent, the Secretary of Health and Human Services, denied that the vaccine caused Ms. Cornelius's injuries.

Despite this disagreement, the parties reached a joint stipulation to settle the case. Under the terms of the stipulation, the respondent agreed to pay Ms.

Cornelius a lump sum of $82,500.00 as compensation for all damages available under the program, including pain and suffering, past lost wages, and past unreimbursed expenses. The decision adopted the stipulation and directed the clerk to enter judgment accordingly.

The petition was filed on February 22, 2019, and the decision on the stipulation was issued on March 19, 2019.

Source PDFs 2 total · 1 downloaded